BCR/ABL1 Extra Fusions in Patients with Chronic Myeloid Leukaemia (CML)

QR Code

BCR/ABL1 Extra Fusions in Patients with Chronic Myeloid Leukaemia (CML)

None

Saved in:

Bibliographic Details
Main Author:	Vargas, Maria Teresa
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/25036
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

De Novo Acquisition of BCR-ABL Mutations for CML Acquired Resistance
by: Chen, WenYong, et al.
Published: (2011)

BCR-ABL gene amplification in patients with chronic myeloid leukemia and imatinib resistance
by: S. I. Kutzev, et al.
Published: (2022-11-01)

Role of High Dose Imatinib in BCR/ABLpos/Phpos CML
by: Petzer, Andreas L., et al.
Published: (2012)

Deregulated expression of Cdc6 as BCR/ABL-dependent survival factor in chronic myeloid leukemia cells
by: Jia-Hua Zhang, et al.
Published: (2017-06-01)

Isolated thrombocytosis with BCR::ABL1 gene rearrangement – a distinct entity or a variant of chronic myelogenous leukemia (CML)? Case report and review of literature
by: Vipulkumar Prajapati, et al.
Published: (2025-09-01)

Diagnosis of Acute Myeloid Leukaemia
by: Bacârea, Anca
Published: (2012)

CLINICAL CASE OF TREATMENT OF A PATIENT WITH CHRONIC MYELOID LEUKEMIA WITH A MUTATION BCR-ABL Y253H AND COMORBIDITIES
by: G. Sh. Safuanova, et al.
Published: (2019-05-01)

BCR-ABL Hits at Mitosis; Implications for Chromosomal Instability, Aneuploidy and Therapeutic Strategy
by: Piwocka, Katarzyna, et al.
Published: (2011)

Treatment of Chronic Myeloid Leukaemia: Current Practice and Future Prospects
by: Zisterer, Daniela M.
Published: (2012)

Retrospective analysis of own long-term experience in studying the BCR::ABL kinase domain mutational status in patients with chronic myeloid leukemia
by: D. V. Kustova, et al.
Published: (2024-09-01)

3D-QSAR Design of New Bcr-Abl Inhibitors Based on Purine Scaffold and Cytotoxicity Studies on CML Cell Lines Sensitive and Resistant to Imatinib
by: David Cabezas, et al.
Published: (2025-06-01)

The comparative analysis of BCR-ABL/ABL detection by real-time quantitative PCR and automated GeneXpert Dx System in chronic myeloid leukemia patients with major and complete molecular response
by: S. A. Smirnikhina, et al.
Published: (2014-07-01)

From the bench of molecular understanding to the bedside of optimal therapy for BCR::ABL1 and ABL-class acute lymphoblastic leukemia in children and adolescents
by: Sarah K. Tasian, et al.
Published: (2025-12-01)

BCR‐ABL enhances the prolyl isomerase activity of Pin 1 by interacting with DAPK1 in ph+ ALL
by: Wen‐bin Cao, et al.
Published: (2018-06-01)

Computational Insights into the Polypharmacological Landscape of BCR-ABL Inhibitors: Emphasis on Imatinib and Nilotinib
by: Rima Hajjo, et al.
Published: (2025-06-01)

THE HISTORY OF CHRONIC MYELOID LEUKEMIA (CML): FROM ARSENIC TO TYROSINE KINASE INHIBITORS (TKI)
by: Rüdiger Hehlmann
Published: (2025-07-01)

Epidemiological characterization of chronic myeloid leukaemia patients at an oncologic centre: A retrospective observational study
by: Ana Maria Meireles, et al.
Published: (2025-07-01)

Targeting HSPA8 to repress GPX4 and induce ferroptosis in BCR-ABL positive leukemia
by: Shuxin Zhong, et al.
Published: (2025-09-01)

Heat Shock Proteins in Chronic Lymphocytic Leukaemia
by: Dempsey-Hibbert, Nina C., et al.
Published: (2012)

Electrochemical sensors for anticancer drugs used in the targeted therapy of chronic myeloid leukaemia
by: Totka Dodevska
Published: (2025-07-01)

Тактика выявления частых и редких типов химерного транскрипта BCR-ABL при хроническом миелоидном лейкозе
by: О. В. Никулина, et al.
Published: (2015-04-01)

Towards the Cure of CML by the Molecular Approach Strategy
by: Cea, Michele, et al.
Published: (2012)

Pathophysiology of Protein Kinase C Isozymes in Chronic Lymphocytic Leukaemia
by: Allen, John C., et al.
Published: (2012)

Improving chronic myeloid leukemia management and quality of life: patient and physician survey on unmet needs from the CML SUN survey
by: Fabian Lang, et al.
Published: (2025-07-01)

Study of Expression of <i>MST3</i> in Myeloid Leukaemia
by: Boro Arthi, et al.
Published: (2025-04-01)

Lower-intensity chemo-immunotherapy with cladribine, low-dose cytarabine, venetoclax and blinatumomab produces high response rates in patients with <i>BCR::ABL1</i>-negative B-cell / myeloid mixed phenotype acute leukemia
by: Roberta S. Azevedo, et al.
Published: (2025-06-01)

Pro-Inflammatory Cytokines in Patients With Chronic Phase-Chronic Myeloid Leukaemia Treated With Imatinib: Any Role in the Monitoring of Treatment Response?
by: Kehinde A. Taiwo, et al.
Published: (2025-06-01)

Cellular hierarchy for understanding heterogeneity of acute myeloid leukaemia with t(8;21)/RUNX1‐RUNX1T1
by: Yibo Wu, et al.
Published: (2025-01-01)

Atypical Presentation of Acute Myeloid Leukaemia: A Series of Three Cases
by: Govind Shiddapur, et al.
Published: (2025-07-01)

International CML forum
by: A. G. Turkina
Published: (2022-11-01)

Stomach Cancer in a Patient with Chronic Lymphocytic Leukaemia
by: R. A. Maier, et al.
Published: (2019-07-01)

The Role of Polymorphisms in Co-Signalling Molecules’ Genes in Susceptibility to B-Cell Chronic Lymphocytic Leukaemia
by: Karabon, Lidia, et al.
Published: (2012)

Myeloid/natural killer cell precursor acute leukaemia. Case report and literature review
by: V. R. Gorodetsky, et al.
Published: (2022-11-01)

Haptoglobin and Glutamine Synthetase May Biomark Cachexia Induced by Antiacute Myeloid Leukaemia Chemotherapy
by: Dean G. Campelj, et al.
Published: (2025-06-01)

Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients
by: Takahashi, Naoto, et al.
Published: (2012)

The Proteasome as a Therapeutic Target in Chronic Myeloid Leukemia
by: Pérez-Roger, Ignacio, et al.
Published: (2011)

Increase in serum IL-4 in response to venetoclax therapy in xenograft models of acute myeloid leukaemia
by: D. A. Bogdanova, et al.
Published: (2024-07-01)

Do Older Indonesian with Chronic Disease Still Be Able to Engage in an Activity and Feel Happy?
by: Santi SULANDARI, et al.
Published: (2020-08-01)

Do Older Indonesian with Chronic Disease Still Be Able to Engage in an Activity and Feel Happy?
by: Santi SULANDARI, et al.
Published: (2020-08-01)

Diagnostics of Molecular Markers in Childhood Acute Leukaemia Using Biochips
by: Nasedkina, Tatyana, et al.
Published: (2011)